Misako Nakayama Selected Research

Misako Nakayama Research Topics

Disease

16	Infections 01/2024 - 08/2009
11	Influenza in Birds (Avian Flu) 01/2022 - 12/2009
7	Virus Diseases (Viral Diseases) 01/2023 - 12/2009
6	Human Influenza (Influenza) 01/2022 - 01/2013
5	COVID-19 01/2024 - 01/2021
3	Inflammation (Inflammations) 10/2023 - 01/2021
3	Neoplasms (Cancer) 01/2021 - 11/2017
2	Fever (Fevers) 01/2023 - 11/2010
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 01/2022
2	Severe Acute Respiratory Syndrome 01/2022 - 01/2021
2	Pneumonia (Pneumonitis) 11/2021 - 02/2010
2	Viral Pneumonia 01/2021 - 01/2017
2	Body Weight (Weight, Body) 08/2014 - 11/2011
1	Rheumatoid Arthritis 01/2024
1	Experimental Arthritis 01/2024
1	Thrombosis (Thrombus) 10/2023
1	Critical Illness (Critically Ill) 10/2023
1	Fibrosis (Cirrhosis) 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021
1	Teratoma (Teratoid Tumor) 01/2021
1	Lung Injury 01/2020
1	Endometriosis 02/2018
1	Non-Muscle Invasive Bladder Neoplasms 01/2018
1	Embryonal Carcinoma 11/2017
1	Glioblastoma (Glioblastoma Multiforme) 11/2017
1	Anaphylaxis (Anaphylactic Shock) 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Vaccinia 11/2016
1	Body Temperature Changes 08/2014
1	Disease Progression 06/2014

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 01/2022 - 12/2009
7	Antiviral Agents (Antivirals)IBA 01/2023 - 06/2014
5	CytokinesIBA 01/2023 - 01/2013
4	Interleukin-6 (Interleukin 6)IBA 01/2024 - 11/2010
4	Neutralizing AntibodiesIBA 12/2022 - 08/2009
4	Neuraminidase (Sialidase)IBA 11/2021 - 08/2014
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2024 - 11/2017
2	Monoclonal AntibodiesIBA 10/2023 - 06/2014
2	ProteomeIBA 10/2023 - 01/2022
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022 - 01/2017
2	LectinsIBA 01/2022 - 01/2022
2	Formaldehyde (Formol)FDA Link 01/2022 - 12/2016
2	Ether (Diethyl Ether)IBA 01/2022 - 01/2021
2	Peptides (Polypeptides)IBA 11/2021 - 01/2012
2	peramivirIBA 08/2014 - 11/2011
1	FibrinIBA 01/2024
1	Antirheumatic Agents (DMARD)IBA 01/2024
1	EnzymesIBA 01/2024
1	CollagenIBA 01/2024
1	Amino Acids FDA Link 01/2024
1	Dichlororibofuranosylbenzimidazole (DRB)IBA 01/2024
1	NAD (NADH)IBA 01/2024
1	Messenger RNA (mRNA)IBA 01/2024
1	EpitopesIBA 01/2024
1	Complement Factor D (Factor D)IBA 10/2023
1	Complement System Proteins (Complement)IBA 10/2023
1	Complement Factor B (Factor B)IBA 10/2023
1	Histocompatibility Antigens Class IIBA 01/2023
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2023
1	SmokeIBA 01/2023
1	Cyclooxygenase InhibitorsIBA 01/2023
1	ProstaglandinsIBA 01/2023
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2023
1	Propiolactone FDA Link 01/2022
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2022
1	Virus ReceptorsIBA 01/2022
1	Sialic AcidsIBA 01/2022
1	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Oseltamivir (Tamiflu)FDA Link 11/2021
1	Hemagglutinins (Hemagglutinin)IBA 11/2021
1	Viral Envelope ProteinsIBA 11/2021
1	Zanamivir (Relenza)FDA Link 11/2021
1	InterferonsIBA 01/2021
1	Detergents (Detergent)IBA 01/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	Viral RNAIBA 01/2021
1	Interferon-alpha (Interferon Alfa)IBA 01/2020
1	Clarithromycin (Biaxin)FDA LinkGeneric 11/2019
1	MacrolidesIBA 11/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2018
1	AutoantibodiesIBA 11/2017
1	glucose-regulated proteinsIBA 11/2017
1	Interleukin-13IBA 01/2017
1	Immunoglobulin E (IgE)IBA 01/2017
1	Immunoglobulin A (IgA)IBA 01/2017
1	avian influenza A virus hemagglutininIBA 11/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 08/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2014
1	Interferon-gamma (Interferon, gamma)IBA 08/2014
1	Interleukin-12 Subunit p40IBA 08/2014
1	ChemokinesIBA 01/2013
1	NucleoproteinsIBA 01/2012

Therapy/Procedure

2	Transplantation 01/2021 - 11/2017
2	Therapeutics 01/2020 - 06/2014
2	Intranasal Administration 01/2017 - 12/2009
1	Autologous Transplantation 01/2021
1	Transurethral Resection of Bladder 01/2018
1	Intravenous Administration 08/2014